Cargando…
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer
Prostate cancer (PCa) ranges from indolent to aggressive tumors that may rapidly progress and metastasize. The switch to aggressive PCa is fostered by reactive stroma infiltrating tumor foci. Therefore, reactive stroma-based biomarkers may potentially improve the early detection of aggressive PCa, a...
Autores principales: | Doldi, Valentina, Lecchi, Mara, Ljevar, Silva, Colecchia, Maurizio, Campi, Elisa, Centonze, Giovanni, Marenghi, Cristina, Rancati, Tiziana, Miceli, Rosalba, Verderio, Paolo, Valdagni, Riccardo, Gandellini, Paolo, Zaffaroni, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324424/ https://www.ncbi.nlm.nih.gov/pubmed/35887333 http://dx.doi.org/10.3390/ijms23147987 |
Ejemplares similares
-
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
por: Gandellini, Paolo, et al.
Publicado: (2021) -
miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition
por: El Bezawy, Rihan, et al.
Publicado: (2019) -
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation
por: Doldi, Valentina, et al.
Publicado: (2015) -
Matricellular Protein Periostin Promotes Pericyte Migration in Fibrotic Airways
por: Bignold, Rebecca E., et al.
Publicado: (2021) -
Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression
por: González-González, Laura, et al.
Publicado: (2018)